CREFX
Price
$17.23
Change
+$0.28 (+1.65%)
Updated
Apr 17 closing price
Net Assets
7.96B
IVRTX
Price
$27.09
Change
+$0.41 (+1.54%)
Updated
Apr 17 closing price
Net Assets
149.39M
Ad is loading...

CREFX vs IVRTX

Header iconCREFX vs IVRTX Comparison
Open Charts CREFX vs IVRTXBanner chart's image
Cohen & Steers Real Estate Securities F
Price$17.23
Change+$0.28 (+1.65%)
VolumeN/A
Net Assets7.96B
VY® CBRE Real Estate S2
Price$27.09
Change+$0.41 (+1.54%)
VolumeN/A
Net Assets149.39M
CREFX vs IVRTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CREFX vs. IVRTX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CREFX is a StrongBuy and IVRTX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CREFX has more cash in the bank: 7.97B vs. IVRTX (149M). CREFX pays higher dividends than IVRTX: CREFX (2.80) vs IVRTX (2.37). CREFX was incepted earlier than IVRTX: CREFX (8 years) vs IVRTX (23 years). IVRTX (1.43) is less costly to investors than CREFX (0.75). IVRTX is a more actively managed with annual turnover of: 73.00 vs. CREFX (41.00). CREFX (0) and IVRTX (0) have matching initial minimum investment requirements. CREFX annual gain was more profitable for investors over the last year : 15.41 vs. IVRTX (7.55). CREFX return over 5 years is better than : 36.49 vs. IVRTX (-1.78).
CREFXIVRTXCREFX / IVRTX
Total Expense Ratio0.751.1565%
Annual Report Gross Expense Ratio0.751.4352%
Fund Existence8 years23 years-
Gain YTD-1.207-5.92420%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets7.97B149M5,346%
Annual Yield % from dividends2.802.37118%
Returns for 1 year15.417.55204%
Returns for 3 years-10.36-34.3330%
Returns for 5 years36.49-1.78-2,054%
Returns for 10 yearsN/A-8.77-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTCH29.020.37
+1.29%
Match Group
VINC0.28N/A
N/A
Vincerx Pharma Inc
FPI9.99-0.04
-0.40%
Farmland Partners
LCTX0.41-0.01
-1.63%
Lineage Cell Therapeutics
DAVA17.10-0.30
-1.72%
Endava plc